Discovery & Innovation

I’ve been thinking a lot lately about how to optimize for ligand affinity. Of course, this is a central theme of all drug discovery projects. At...

Anyone who has taken a general laboratory class knows that the lab manual has multiple protocols that one follows in order to complete each week’s...

Innovation is suddenly the word on everybody’s lips. Pfizer launched “Centers for Therapeutic Innovation”, Johnson and Johnson followed with their...

Sometimes, in tragic circumstances, a lesson can be learned and applied in unexpected ways. That appears to be the case with a rare disease that...

We have recently discussed here how crowdfunding – donations from the general public in support of a cause, idea, or invention – has caught the...

As we previously discussed, CRISPR-mania is sweeping the globe. (Okay, it might not be as big as Beatlemania, but more than a few life science...

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...

Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major therapeutic areas targeted by drug...

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug...

Outsourcing has proven to reduce costs while dramatically improving productivity of the drug discovery process. Primary benefits to outsourcing...